Blood Test Detects Dozens Of Cancers Early [Forbes]
Illumina, Inc. (ILMN)
Last illumina, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
illumina.com/company/investor-information.html
Company Research
Source: Forbes
The PATHFINDER 2 study of the Galleri multi-cancer early detection (MCED) test showed a more than seven-fold increase in cancer detection rates when added to standard recommended screenings. Major Breakthrough in Cancer Screening Results presented at the Eur opean Society for Medical Oncology Congress 2025 in Berlin revealed that more than half of the cancers detected were at an early stage (stage I or II), when they are most treatable. Approximately three-quarters of the cancers detected have no existing standard screening program—such as pancreatic, liver, ovarian, and stomach cancers. “Cancer is the second leading cause of death worldwide as most deadly cancers are found too late,” said Dr. Josh Ofman, President of GRAIL , Inc. . “Adding Galleri to recommended screening yielded a more than seven-fold increase in the cancer detection rate, and more than half of the Galleri-detected new cancers were found in early stages, when cancers are more treatable and potentially even cur
Show less
Read more
Impact Snapshot
Event Time:
ILMN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ILMN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ILMN alerts
High impacting Illumina, Inc. news events
Weekly update
A roundup of the hottest topics
ILMN
News
- Illumina (NASDAQ:ILMN) had its "hold (c-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Illumina (NASDAQ:ILMN) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.MarketBeat
- Illumina (NASDAQ:ILMN) was upgraded by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from a "sell (d+)" rating to a "hold (c-)" rating.MarketBeat
- Preimplantation Genetic Testing Market Size to Reach USD 1849.38 Million by 2032 – SNS Insider [Yahoo! Finance]Yahoo! Finance
- Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study [Yahoo! Finance]Yahoo! Finance
ILMN
Earnings
- 10/30/25 - Beat
ILMN
Sec Filings
- 11/25/25 - Form 8-K
- 11/13/25 - Form SCHEDULE
- 11/12/25 - Form 8-K
- ILMN's page on the SEC website